ATF4 and Miyoshi myopathy: Purity of CD138+-MM cells was proven by checking SDC1 (CD138) gene expression and a set of established myeloma-marker/differentiation factors, such as MZB1 (marginal zone B and B1 cell-specific protein), XBP1 (x-box binding protein 1), IRF4 (interferon regulatory factor 4, MUM-1), SLAM7 (activating transcription factor 4), and TNF receptor superfamily member 17 (BCMA) in direct comparison to PBMNCs of healthy donors (Figure 4B).